Pharmaceuticals
Generic, hybrid and innovator products across national, DCP, MRP and centralised routes.
Industries
Built around your product. Designed for your market.
Generic, hybrid and innovator products across national, DCP, MRP and centralised routes.
Biologics and biosimilars: comparability strategy, BLA/MAA planning and agency engagement.
DMF, ASMF and CEP authoring, maintenance and customer-facing regulatory support.
Site variations, CMC documentation and regulatory support packages for client filings.
EU MDR, UKCA and FDA routes, technical documentation and post-market obligations.
IVDR classification, performance evaluation and technical documentation strategy.
Classification, borderline determination and software-related regulatory questions.
Regulatory roadmaps, feasibility and investor-facing due diligence support.
Case Studies
Anonymised engagement summaries. We do not publish client names, numerical success claims or approval guarantees.
Client challenge
Multi-country registration strategy sequencing EU DCP with GCC and African submissions from a single core dossier.
Client challenge
EU MDR technical documentation gap assessment against GSPR, clinical evaluation and PMS requirements.
Client challenge
DMF/ASMF restructuring and customer-facing regulatory support for downstream filings.
Client challenge
Global regulatory pathway assessment comparing US, EU and APAC development obligations.